Register Login
Register to leave comments
  • News bot May 5, 2026, 8:26 p.m.

    📋 ADAPTIVE BIOTECHNOLOGIES CORP (ADPT) - Financial Results

    Filing Date: 2026-05-05

    Accepted: 2026-05-05 16:15:23

    Event Type: Financial Results

    Event Details:

    ADAPTIVE BIOTECHNOLOGIES CORP (ADPT) Reports the reporting period Financial Results ADAPTIVE BIOTECHNOLOGIES CORP (ADPT) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: 3781
    • Net Income: 3362
    • EPS: Not disclosed
    • Cash and equivalents: 77581

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Revenue 70.87K 52.44K $18.43K +35.14%
    Operating Expenses Loss From Operations 19.21K 29.60K $-10.40K -35.12%
    Operating Expenses Interest Expense 2.89K 2.90K $-16.00 -0.55%
    Operating Expenses Net Loss 20.02K 29.83K $-9.81K -32.90%
    Current Assets Prepaid Expenses Other Current Assets 13.95K 13.02K $932.00 +7.16%
    Longterm Assets Property Equipment Net 30.77K 34.11K $-3.33K -9.77%
    Longterm Assets Operating Lease Right Of Use Assets 40.25K 40.62K $-368.00 -0.91%
    Longterm Assets Intangible Assets Net 1.31K 1.73K $-419.00 -24.28%
    Longterm Assets Other Assets 1.24K 1.21K $30.00 +2.49%
    Current Liabilities Accounts Payable 9.62K 6.47K $3.15K +48.68%
    Current Liabilities Accrued Liabilities 7.46K 7.70K $-235.00 -3.05%
    Longterm Liabilities Other Long Term Liabilities 20.00 20.00 $0.00 +0.00%
    Preferred Stock Par Value Shares Authorized At March And December No Shares Issued And Outstanding At March And December Noncontrolling Interests 7.90K 6.21K $1.69K +27.27%
    Interest Expense 2.89K 2.90K $-16.00 -0.55%
    Mrd Revenue 67.09K 43.72K $23.37K +53.46%
    Immune Medicine Revenue 3.78K 8.72K $-4.94K -56.65%
    Reconciliation Of Net Loss To Adjusted Ebitda Net Loss 15.93K 10.92K $5.01K +45.88%
    Revenue 70.87K 52.44K $18.43K +35.14%
    Loss from Operations 19.21K 29.60K $-10.40K -35.12%
    Other Income, Net 2.08K 2.68K $-599.00 -22.36%
    Interest Expense 2.89K 2.90K $-16.00 -0.55%
    Net Loss 20.02K 29.83K $-9.81K -32.90%
    Prepaid Expenses and Other Current Assets 13.95K 13.02K $932.00 +7.16%
    Property and Equipment, Net 30.77K 34.11K $-3.33K -9.77%
    Intangible Assets, Net 1.31K 1.73K $-419.00 -24.28%
    Other Assets 1.24K 1.21K $30.00 +2.49%
    Accounts Payable 9.62K 6.47K $3.15K +48.68%
    Accrued Liabilities 7.46K 7.70K $-235.00 -3.05%
    Operating Lease Liabilities 8.51K 8.92K $-407.00 -4.56%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval: Not available
    • Executive Changes: Not available

    Structured Data:

    • Company Name: ADAPTIVE BIOTECHNOLOGIES CORP
    • Ticker Symbol: ADPT

Search

News categories